USE OF THE P17 PROTEIN OF HIV IN ISOLATED FORM FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION TO HIV SEROPOSITIVE PATIENTS, AS WELL AS PHARMACEUTICAL COMPOSITIONS COMPRISING SAID PROTEIN

摘要

The invention relates to a medicament for booster antigen use in HIV seropositive patients which uses, as active ingredient, the p17 protein of HIV or variants thereof in isolated or DNA form, containing sequences encoding for p17 or its variants which, if administered alone or combined with anti-inflammatory cytokines and molecules or DNA encoding for anti-inflammatory cytokines, are able to evoke or increase the serum titre of the anti-HIV-p17 antibodies that are capable of neutralizing the immunostimulating activity of the viral protein.